We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$344M
AUM Growth
+$14.9M
Cap. Flow
+$4.56M
Cap. Flow %
1.32%
Top 10 Hldgs %
57.6%
Holding
101
New
11
Increased
48
Reduced
15
Closed
4

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$1.83M
2
FIS icon
Fidelity National Information Services
FIS
+$1.02M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$538K
4
MSFT icon
Microsoft
MSFT
+$493K
5
AMZN icon
Amazon
AMZN
+$412K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.2M
2
XOM icon
ExxonMobil
XOM
+$1.76M
3
GILD icon
Gilead Sciences
GILD
+$1.45M
4
KEYS icon
Keysight
KEYS
+$1.22M
5
AGN
Allergan plc
AGN
+$683K

Sector Composition

Rank Sector Weight
1 Healthcare 36.49%
2 Industrials 17.6%
3 Technology 12.63%
4 Energy 11.69%
5 Financials 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
101
Pfizer
PFE
$140B
– –
-2,822
Closed -$114K
1 2 3 4
5

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Aristotle Atlantic Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Aristotle Atlantic Partners held 101 positions worth $344M, up 4.5% from $329M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Aristotle Atlantic Partners's Q2 2019 filing shows 11 new, 48 increased, 15 reduced and 4 closed positions. Its largest new stake was Illumina: 5,785 shares worth $2.07M. The largest sale was Celgene Corp, an estimated $2.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 37% a quarter earlier, followed by Industrials and Technology.

  • Aristotle Atlantic Partners's largest Q2 2019 buy was Illumina: 5,785 shares worth $2.07M.
  • Aristotle Atlantic Partners added most to Microsoft in Q2 2019, an estimated $493K increase.
  • Aristotle Atlantic Partners's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $2.2M.
  • Aristotle Atlantic Partners fully exited Keysight in Q2 2019, selling an estimated $1.22M.
  • Aristotle Atlantic Partners's ten largest holdings make up 58% of its $344M portfolio in Q2 2019.
  • Aristotle Atlantic Partners opened 11 new positions and closed 4 in Q2 2019.
  • Aristotle Atlantic Partners's portfolio value rose 4.5% quarter-over-quarter to $344M.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2019, filed 13 Aug 2019.